Court Denies FTC Bid to Block Surmodics Acquisition by GTCR
Surmodics, Inc. announced that the U.S. District Court for the Northern District of Illinois has denied the FTC's request to block its acquisition by GTCR LLC. However, the acquisition is still subject to a temporary restraining order that prevents closing before November 17, 5:00 p.m. Central time, along with other customary closing conditions. This court decision is a significant step forward for Surmodics in the acquisition process.
Surmodics, Inc., a provider of medical device and in vitro diagnostic technologies, reported that the United States District Court for the Northern District of Illinois has denied a request by the Federal Trade Commission and certain state regulators to issue a preliminary injunction that would have blocked its proposed acquisition by an affiliate of GTCR LLC. The company stated that while this court decision is a significant step forward, the completion of the acquisition is still subject to a temporary restraining order preventing the deal from closing before 5:00 p.m. Central time on Monday, November 17, as well as the satisfaction or waiver of other customary closing conditions outlined in the merger agreement. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SurModics Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20251110939371) on November 11, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT)
